Your browser doesn't support javascript.
loading
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands.
Weinreb, Ilan; Piscuoglio, Salvatore; Martelotto, Luciano G; Waggott, Daryl; Ng, Charlotte K Y; Perez-Ordonez, Bayardo; Harding, Nicholas J; Alfaro, Javier; Chu, Kenneth C; Viale, Agnes; Fusco, Nicola; da Cruz Paula, Arnaud; Marchio, Caterina; Sakr, Rita A; Lim, Raymond; Thompson, Lester D R; Chiosea, Simion I; Seethala, Raja R; Skalova, Alena; Stelow, Edward B; Fonseca, Isabel; Assaad, Adel; How, Christine; Wang, Jianxin; de Borja, Richard; Chan-Seng-Yue, Michelle; Howlett, Christopher J; Nichols, Anthony C; Wen, Y Hannah; Katabi, Nora; Buchner, Nicholas; Mullen, Laura; Kislinger, Thomas; Wouters, Bradly G; Liu, Fei-Fei; Norton, Larry; McPherson, John D; Rubin, Brian P; Clarke, Blaise A; Weigelt, Britta; Boutros, Paul C; Reis-Filho, Jorge S.
Afiliação
  • Weinreb I; Department of Pathology, University Health Network, Toronto, Ontario, Canada.
  • Piscuoglio S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Martelotto LG; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Waggott D; 1] Informatics and Bio-Computing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. [2] Ontario Cancer Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Onatrio, Canada. [3] Campbell Family Institute for Cancer Research, Princess Margaret Cancer C
  • Ng CK; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Perez-Ordonez B; Department of Pathology, University Health Network, Toronto, Ontario, Canada.
  • Harding NJ; Informatics and Bio-Computing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Alfaro J; 1] Informatics and Bio-Computing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. [2] Ontario Cancer Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Onatrio, Canada. [3] Campbell Family Institute for Cancer Research, Princess Margaret Cancer C
  • Chu KC; Informatics and Bio-Computing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Viale A; Integrated Genomics Operation, Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Fusco N; 1] Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. [2] School of Pathology, University of Milan, Milan, Italy.
  • da Cruz Paula A; 1] Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. [2] Instituto Português de Oncologia, Oporto, Portugal.
  • Marchio C; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Sakr RA; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Lim R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Thompson LD; Department of Pathology, Kaiser Permanente, Woodland Hills Medical Center, Woodland Hills, California, USA.
  • Chiosea SI; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Seethala RR; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Skalova A; Department of Pathology and Laboratory Medicine, Charles University in Prague, Plzen, Czech Republic.
  • Stelow EB; Department of Pathology, University of Virginia Medical Center, Charlottesville, Virginia, USA.
  • Fonseca I; 1] Instituto Português de Oncologia Francisco Gentil, Lisbon, Portugal. [2] Faculdade de Medicina de Lisboa, Lisbon, Portugal.
  • Assaad A; Department of Pathology, Virginia Mason Hospital and Seattle Medical Center, Seattle, Washington, USA.
  • How C; 1] Ontario Cancer Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Onatrio, Canada. [2] Campbell Family Institute for Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Wang J; Informatics and Bio-Computing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • de Borja R; Informatics and Bio-Computing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Chan-Seng-Yue M; Informatics and Bio-Computing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Howlett CJ; Western University, London, Ontario, Canada.
  • Nichols AC; Western University, London, Ontario, Canada.
  • Wen YH; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Katabi N; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Buchner N; Cancer Genomics Platform, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Mullen L; Cancer Genomics Platform, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Kislinger T; 1] Ontario Cancer Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Onatrio, Canada. [2] Campbell Family Institute for Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. [3] Department of Medical Biophysics, University
  • Wouters BG; 1] Ontario Cancer Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Onatrio, Canada. [2] Campbell Family Institute for Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. [3] Department of Medical Biophysics, University
  • Liu FF; 1] Ontario Cancer Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Onatrio, Canada. [2] Campbell Family Institute for Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. [3] Department of Medical Biophysics, University
  • Norton L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • McPherson JD; 1] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. [2] Department of Pathology, Virginia Mason Hospital and Seattle Medical Center, Seattle, Washington, USA.
  • Rubin BP; 1] Department of Molecular Genetics, Lerner Research Institute, Cleveland, Ohio, USA. [2] Robert J. Tomsich Pathology and Laboratory Medicine Institute, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio, USA.
  • Clarke BA; Department of Pathology, University Health Network, Toronto, Ontario, Canada.
  • Weigelt B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Boutros PC; 1] Informatics and Bio-Computing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. [2] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. [3] Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
  • Reis-Filho JS; 1] Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. [2].
Nat Genet ; 46(11): 1166-9, 2014 Nov.
Article em En | MEDLINE | ID: mdl-25240283
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Quinase C / Neoplasias das Glândulas Salivares / Adenocarcinoma / Modelos Moleculares Limite: Animals / Humans Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Quinase C / Neoplasias das Glândulas Salivares / Adenocarcinoma / Modelos Moleculares Limite: Animals / Humans Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Canadá